Combining physiologically based pharmacokinetic modeling with Monte Carlo simulation to derive an acute inhalation guidance value for trichloroethylene

Regulatory Toxicology and Pharmacology : RTP
T W Simon

Abstract

Using the Monte Carlo method and physiologically based pharmacokinetic modeling, an occupational inhalation exposure to trichloroethylene consisting of 7 h of exposure per day for 5 days was simulated in populations of men and women of 5000 individuals each. The endpoint of concern for occupational exposure was drowsiness. The toxicologic condition leading to drowsiness was assumed to be high levels of both trichloroethanol and trichloroethylene. Therefore, the output of the simulation or dose metric was the maximum value of the sum of the concentration of trichloroethylene in blood and the concentration of trichloroethanol within its volume of distribution occurring within 1 week of exposure. The distributions of the dose metric in the simulated populations were lognormal. To protect 99% of a worker population, a concentration of 30 ppm over a 7-h period of the work day should not be exceeded. Subjecting a susceptible individual (the 99th percentile of the dose metric) to 200 ppm (the ACGIH short-term exposure limit or STEL) for 15 min twice a day over a work week necessitates a 2.5-h rest in fresh air following the STEL exposure to allow the blood concentrations of trichloroethylene and trichloroethanol to drop to levels that...Continue Reading

References

Oct 1, 1978·Journal of Clinical Pharmacology·E M SellersJ Koch-Weser
Dec 1, 1976·Scandinavian Journal of Work, Environment & Health·O VesterbergM Krasts
Apr 1, 1992·Pharmacogenetics·D P Agarwal, H W Goedde
Mar 1, 1991·Food Additives and Contaminants·A G Renwick
Aug 1, 1989·Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Für Medizinische Physik and the European Federation of Organisations for Medical Physics·L R Williams, R W Leggett
Mar 15, 1989·Toxicology and Applied Pharmacology·M L GargasM E Andersen
Dec 1, 1988·Regulatory Toxicology and Pharmacology : RTP·D G Barnes, M Dourson
Feb 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·W DekantD Henschler
Jun 1, 1985·Regulatory Toxicology and Pharmacology : RTP·E J Calabrese
Jan 1, 1970·Archives of Environmental Health·R D StewartD S Erley
Sep 1, 1983·Regulatory Toxicology and Pharmacology : RTP·M L Dourson, J F Stara
Feb 1, 1980·British Journal of Industrial Medicine·V Fiserova-BergerovaJ C Cassady
Oct 1, 1995·Risk Analysis : an Official Publication of the Society for Risk Analysis·W J CroninC D Flemming
Feb 1, 1995·Regulatory Toxicology and Pharmacology : RTP·J LiptonA Patterson
Mar 1, 1994·Epidemiology·H M Arrighi, I Hertz-Picciotto
Feb 1, 1993·Risk Analysis : an Official Publication of the Society for Risk Analysis·B C Allen, J W Fisher
Feb 1, 1993·Risk Analysis : an Official Publication of the Society for Risk Analysis·J W Fisher, B C Allen
Dec 1, 1995·Alcoholism, Clinical and Experimental Research·H R ThomassonT K Li
Oct 14, 1996·Biochemical and Biophysical Research Communications·J C LipscombC M Garrett
Jun 1, 1996·Journal of Molecular Graphics·W Smith, T R Forester
Oct 1, 1996·Regulatory Toxicology and Pharmacology : RTP·M L DoursonD Robinson
May 1, 1996·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·R S ThomasR S Yang
Feb 1, 1997·Regulatory Toxicology and Pharmacology : RTP·K T Bogen, L S Gold
Feb 1, 1997·Toxicology and Applied Pharmacology·J C LipscombJ E Snawder

❮ Previous
Next ❯

Citations

Feb 9, 2006·Journal of Occupational and Environmental Hygiene·Ginette TruchonGuillaume Pierrehumbert
Jun 14, 2000·Critical Reviews in Toxicology·T Brüning, H M Bolt
Dec 4, 2003·Risk Analysis : an Official Publication of the Society for Risk Analysis·Michael PelekisJoseph S Gauthier
Nov 10, 2015·Journal of Occupational and Environmental Hygiene·Eileen D KuempelAnnie M Jarabek
Sep 20, 2005·Regulatory Toxicology and Pharmacology : RTP·J C AdamsC H Pierce
Dec 16, 1998·Toxicology and Applied Pharmacology·J C LipscombJ Z Byczkowski
Mar 13, 2014·Regulatory Toxicology and Pharmacology : RTP·Anna-Karin MörkGunnar Johanson
Jan 1, 2008·Toxicology Mechanisms and Methods·Eugene DemchukChristopher T De Rosa
Nov 5, 2003·Critical Reviews in Toxicology·Paul S PriceDouglas R Tedder
Mar 28, 2007·Journal of the Air & Waste Management Association·Robert L BuckleyMatthew J Parker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.